Kohinoor Foods Limited (KOHINOOR.BO)
INR 40.67
(-1.93%)
INR 40.67
(-1.93%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 102.68 Million | 215.04 Million | 790.74 Million | -16.24 Million | -631.6 Million | 610.79 Million |
| Net Income | -45.5 Million | -48.61 Million | -55.2 Million | 247.11 Million | -1.76 Billion | -3.12 Billion |
| Depreciation & Amortization | 63.1 Million | 67.14 Million | 77.25 Million | 101.17 Million | 121.24 Million | 146.35 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 134.78 Million | 21.82 Million | 746.13 Million | -334.18 Million | -541.94 Million | 2.91 Billion |
| Other non-cash items | 98.63 Million | 174.69 Million | 22.56 Million | -30.35 Million | 1.55 Billion | 669.55 Million |
| Investing Cash Flow | -48.22 Million | -1.24 Million | 46.09 Million | -153 Thousand | 443.76 Million | 84.58 Million |
| Investments in PPE | -53.38 Million | -7.59 Million | - | -4.94 Million | - | - |
| Acquisitions | - | - | 59.75 Million | - | 439.02 Million | 78.21 Million |
| Investment purchases | - | - | -18.49 Million | - | - | - |
| Sales/Maturities of investments | - | 1.12 Million | - | - | - | - |
| Other Investing Activities | 5.16 Million | 5.23 Million | 4.82 Million | 4.78 Million | 4.74 Million | 6.36 Million |
| Financing Cash Flow | -67.88 Million | -210.16 Million | -837.81 Million | -11.31 Million | 194.97 Million | -774.24 Million |
| Debt repayment | -67.88 Million | -30.23 Million | -831.06 Million | -36.43 Million | -262.76 Million | -722.58 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 214.77 Million |
| Other Financing Activities | -1000.00 | -179.92 Million | -6.75 Million | 25.11 Million | 457.74 Million | -266.43 Million |
| Accounts receivables | -65.69 Million | -23.56 Million | 937.42 Million | -34.21 Million | -343.78 Million | -1.1 Billion |
| Accounts payables | 84.53 Million | -4.82 Million | -234 Million | -163.53 Million | -171.56 Million | - |
| Inventory | -40.95 Million | -3.9 Million | 303.36 Million | -123.67 Million | -16.98 Million | 5.26 Billion |
| Other working capital | 156.9 Million | 54.11 Million | -260.64 Million | -12.76 Million | -9.6 Million | -1.24 Billion |
| Cash at beginning of period | 17.71 Million | 14.32 Million | 15.3 Million | 43.02 Million | 35.88 Million | 114.74 Million |
| Cash at end of period | 4.5 Million | 17.96 Million | 14.32 Million | 15.3 Million | 43.02 Million | 35.88 Million |
| Capital Expenditure | -53.38 Million | -7.59 Million | - | -4.94 Million | - | - |
| Effect of forex changes on cash | - | 1000.00 | - | - | -1000.00 | - |
| Net cash flow / Change in cash | -13.21 Million | 3.63 Million | -976 Thousand | -27.71 Million | 7.13 Million | -78.85 Million |
| Free Cash Flow | 49.29 Million | 207.44 Million | 790.74 Million | -21.19 Million | -631.6 Million | 610.79 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.5 Million | -45.5 Million | -4.6 Million | -36 Million | -10.4 Million | -48.61 Million |
| Depreciation & Amortization | - | 63.1 Million | 16.6 Million | 15 Million | 14.5 Million | 67.14 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 134.78 Million | - | - | - | 21.82 Million |
| Other non-cash items | -5.5 Million | 98.63 Million | 4.6 Million | 36 Million | 10.4 Million | 174.69 Million |
| Investing Cash Flow | - | -48.22 Million | - | - | - | -1.24 Million |
| Investments in PPE | - | -53.38 Million | - | - | - | -7.59 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 1.12 Million |
| Other Investing Activities | - | 5.16 Million | - | - | - | 5.23 Million |
| Financing Cash Flow | - | -67.88 Million | - | - | - | -210.16 Million |
| Debt repayment | - | -67.88 Million | - | - | - | -30.23 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -1000.00 | - | - | - | -179.92 Million |
| Accounts receivables | - | -65.69 Million | - | - | - | -23.56 Million |
| Accounts payables | - | 84.53 Million | - | - | - | -4.82 Million |
| Inventory | - | -40.95 Million | - | - | - | -3.9 Million |
| Other working capital | - | 156.9 Million | - | - | - | 54.11 Million |
| Cash at beginning of period | - | 17.71 Million | 31.4 Million | 67.4 Million | 17.71 Million | 14.32 Million |
| Cash at end of period | - | 4.5 Million | 64.6 Million | 31.4 Million | -10.4 Million | 17.96 Million |
| Capital Expenditure | - | -53.38 Million | - | - | - | -7.59 Million |
| Effect of forex changes on cash | - | - | - | - | - | 1000.00 |
| Net cash flow / Change in cash | - | -13.21 Million | 33.2 Million | -36 Million | -28.11 Million | 3.63 Million |
| Free Cash Flow | - | 49.29 Million | 33.2 Million | -36 Million | -10.4 Million | 207.44 Million |
KLINIQ
300031
301190
TIIL
PCSA
0SAY